NEO-BEX INJECTABLE
NEO-BEX INJECTABLE
Dormant
DIN Number
00147680
Drug Class
Human
Market Date
Dec 31, 1951
Company
HC
brostel inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00147680
AIG Number0652644001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
A11EX VITAMIN B-COMPLEX, OTHER COMBINATIONS
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
,
Intravenous
AHFS Classification88:08.00
Health Canada Classification
ACTIVE INGREDIENTS (6)
DEXPANTHENOLActive
Strength: 10 MG / ML
Monograph: DEXPANTHENOL
LIDOCAINE HYDROCHLORIDEActive
Strength: 2 % / W/V
Monograph: LIDOCAINE HYDROCHLORIDE
NICOTINAMIDEActive
Strength: 75 MG / ML
Monograph: NICOTINAMIDE
PYRIDOXINE HYDROCHLORIDEActive
Strength: 2 MG / ML
Monograph: PYRIDOXINE HYDROCHLORIDE
VITAMIN B1Active
Strength: 50 MG / ML
Monograph: VITAMIN B1
VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM)Active
Strength: 7.5 MG / ML
Monograph: VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM)